Guidelines

Consensus paper on antipsychotics:
Advantages and disadvantages of combination treatment with antipsychotics
European Neuropsychopharmacology 19 (2009) 520–532.
The document is the result of discussions during the ECNP Consensus Meeting, 9-12 March 2008, Nice, France.

Consensus paper on bipolar depression:
Bipolar depression
European Neuropsychopharmacology 18 (2008) 535-549.
The document is the result of discussions during the ECNP Consensus Meeting, 11-14 March 2007, Nice, France.

Consensus paper on schizophrenia:
Negative, depressive and cognitive symptoms of schizophrenia
European Neuropsychopharmacology 17 (2007) 70-77.
The document is the result of discussions during the ECNP Consensus Meeting, 14-17 March 2004, Nice, France.

Consensus paper on substance use disorders:
Guidelines for the investigation of efficacy in substance use disorders
European Neuropsychopharmacology 16 (2006) 224-230.
The document is the result of discussions during the ECNP Consensus Meeting, 12-14 March 2003, Nice, France.

Consensus paper on social anxiety disorder:
Guidelines for the investigation of efficacy in social anxiety disorder
European Neuropsychopharmacology 14 (2004) 425-433.
The document is the result of discussions during the ECNP Consensus Meeting, 12-14 March 2003, Nice, France.

Consensus paper on conduct disorder:
Guidelines for investigating efficacy of pharmacological intervention
European Neuropsychopharmacology 13 (2003) 305-311.
The document is the result of discussions during the ECNP Consensus Meeting, 19-21 March 2001, Nice, France.

Consensus paper on attention deficit hyperactivity disorder: 
Guidelines for investigating efficacy of pharmacological intervention
European Neuropsychopharmacology 13 (2003) 297-304.
The document is the result of discussions during the ECNP Consensus Meeting, 19-21 March 2001, Nice, France.

Consensus paper on bipolar disorder:
Guidelines for investigating efficacy in bipolar disorder
European Neuropsychopharmacology 11/1 (2001) 79-88.
The document is the result of discussions during the ECNP Consensus Meeting, 19 - 22 March 2000, Nice, France.

Consensus paper on general anxiety disorder:
Guidelines for investigating Efficacy in GAD
European Neuropsychopharmacology 12/1 (2002) 81-87.
The document is the result of discussions during the ECNP Consensus Meeting, 19 - 22 March 2000, Nice, France.

Consensus paper on post traumatic stress disorder:
Guidelines for investigating efficacy of pharmacological intervention
European Neuropsychopharmacology 10/4 (2000), 297-300.
The document is the result of discussions during the ECNP Consensus Meeting, 5 - 7 March 1999, Nice, France.

Consensus paper on depression:
Is severe depression a separate indication?
European Neuropsychopharmacology 9 (1999) 259-264.
The document is the result of discussions during the ECNP Consensus Meeting, 20 September 1996, Amsterdam, The Netherlands.

Consensus paper on placebo-controlled trials:
Alternatives to placebo-controlled trials in psychiatry
European Neuropsychopharmacology 9 (1999) 265-269.
The document is the result of discussions during the ECNP Consensus Meeting, 26 September 1996, Amsterdam, The Netherlands.

ECNP position paper on social phobia:
Proceedings from an ECNP workshop in Jerusalem, October 1994
European Neuropsychopharmacology 6 (1996) 77-83.

Report of Consensus Meeting:
Clinical relevance of response and improvement in psychopharmacology
European Neuropsychopharmacology 5 (1995) 531-533.
A statement from the European College of Neuropsychopharmacology, from the ECNP Workshop, October 1994, Jerusalem, Israel.